← brief for 2026-09-21 · Slowing decline

Outcomes of SGLT2 inhibitors after transcatheter mitral valve repair in patients with type 2 diabetes mellitus.

Article C Peer reviewed Observational

Key takeaways

This study looked at 325 people with diabetes who had a heart valve repair. It compared those taking a specific kidney-protecting drug to those who were not. It shows a link to outcomes, not proof of cause.

Who did this work

Abdelnabi M · Nhat Pham H · Ibrahim R · Allam M · Pathangey G · Choon Tan M · Lee K · Fortuin FD · Alsidawi S · Ayoub C · Alkhouli M · Arsanjani R

Source

Article · PubMed, the drug frontier · 2026 Aug 27
https://pubmed.ncbi.nlm.nih.gov/42765780/